EA201892802A1 - Производные аденозина для применения при лечении рака - Google Patents

Производные аденозина для применения при лечении рака

Info

Publication number
EA201892802A1
EA201892802A1 EA201892802A EA201892802A EA201892802A1 EA 201892802 A1 EA201892802 A1 EA 201892802A1 EA 201892802 A EA201892802 A EA 201892802A EA 201892802 A EA201892802 A EA 201892802A EA 201892802 A1 EA201892802 A1 EA 201892802A1
Authority
EA
Eurasian Patent Office
Prior art keywords
cancer
treatment
adenosine
derivatives
preparation
Prior art date
Application number
EA201892802A
Other languages
English (en)
Inventor
Хью Гриффит
Микаэла Серпи
Магдалена Слюсарчик
Original Assignee
НУКАНА ПиЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by НУКАНА ПиЭлСи filed Critical НУКАНА ПиЭлСи
Publication of EA201892802A1 publication Critical patent/EA201892802A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C07H19/207—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids the phosphoric or polyphosphoric acids being esterified by a further hydroxylic compound, e.g. flavine adenine dinucleotide or nicotinamide-adenine dinucleotide

Abstract

Настоящее изобретение относится к химическим соединениям, их получению и их применению в лечении рака.
EA201892802A 2016-06-01 2017-05-31 Производные аденозина для применения при лечении рака EA201892802A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1609602.6A GB201609602D0 (en) 2016-06-01 2016-06-01 Chemical compounds
PCT/GB2017/051554 WO2017207989A1 (en) 2016-06-01 2017-05-31 Adenosine derivatives for use in the treatment of cancer

Publications (1)

Publication Number Publication Date
EA201892802A1 true EA201892802A1 (ru) 2019-06-28

Family

ID=56410851

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201892802A EA201892802A1 (ru) 2016-06-01 2017-05-31 Производные аденозина для применения при лечении рака

Country Status (17)

Country Link
US (1) US20190375778A1 (ru)
EP (1) EP3464308B1 (ru)
JP (1) JP2019520345A (ru)
KR (1) KR20190015355A (ru)
CN (1) CN109563122A (ru)
AU (1) AU2017273120A1 (ru)
BR (1) BR112018074972A2 (ru)
CA (1) CA3025435A1 (ru)
CL (1) CL2018003444A1 (ru)
EA (1) EA201892802A1 (ru)
GB (1) GB201609602D0 (ru)
IL (1) IL263120A (ru)
MX (1) MX2018014849A (ru)
PH (1) PH12018502497A1 (ru)
SG (1) SG11201810146SA (ru)
WO (1) WO2017207989A1 (ru)
ZA (1) ZA201807810B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201421083D0 (en) 2014-11-27 2015-01-14 Kalvista Pharmaceuticals Ltd Enzyme inhibitors
DK3224268T3 (da) 2014-11-28 2019-09-02 NuCana plc Nye 2'- og/eller 5'-aminosyreesterphosphoramidat 3'-deoxyadenosinderivater som anti-cancerforbindelser
KR102424709B1 (ko) 2016-05-31 2022-07-22 칼비스타 파마슈티컬즈 리미티드 혈장 칼리크레인 저해제로서 피라졸 유도체
GB201609603D0 (en) 2016-06-01 2016-07-13 Kalvista Pharmaceuticals Ltd Polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)Methyl]-3-(methoxymethyl)-1-({4-[(2-ox opyridin-1-YL)Methyl]phenyl}methyl)pyrazole-4-carboxamide
GB201609607D0 (en) 2016-06-01 2016-07-13 Kalvista Pharmaceuticals Ltd Polymorphs of N-(3-Fluoro-4-methoxypyridin-2-yl)methyl)-3-(methoxymethyl)-1-({4-((2-oxopy ridin-1-yl)methyl)phenyl}methyl)pyrazole-4-carboxamide and salts
GB201709471D0 (en) 2017-06-14 2017-07-26 Nucana Biomed Ltd Diastereoselective synthesis of hosphate derivatives
GB201715011D0 (en) 2017-09-18 2017-11-01 Nucana Biomed Ltd Floxuridine synthesis
HUE057912T2 (hu) 2017-11-29 2022-06-28 Kalvista Pharmaceuticals Ltd Plazma kallikrein inhibitort tartalmazó dózisformák
GB201719881D0 (en) 2017-11-29 2018-01-10 Kalvista Pharmaceuticals Ltd Solid forms of plasma kallikrein inhibitor and salts thereof
GB201720279D0 (en) 2017-12-05 2018-01-17 Nucana Biomed Ltd Anticancer compounds
GB201820685D0 (en) 2018-12-19 2019-01-30 NuCana plc Synthesis of 8-chloroadenosine derivatives
EP4010333A1 (en) 2019-08-09 2022-06-15 Kalvista Pharmaceuticals Limited Plasma kallikrein inhibitors
CN113549076B (zh) * 2021-07-23 2022-12-06 中国药科大学 一种多取代嘌呤类化合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0505781D0 (en) * 2005-03-21 2005-04-27 Univ Cardiff Chemical compounds
SI3235824T1 (sl) * 2012-11-16 2019-08-30 University College Cardiff Consultants Limited Zmes rp / sp gemcitabin-(fenil-(benziloksi-l-alaninil))-fosfata
CN103435672A (zh) * 2013-04-25 2013-12-11 刘沛 含有取代苄基的新型核苷磷酸酯前药的结构与合成
US10030044B2 (en) * 2013-11-27 2018-07-24 Idenix Pharmaceuticals Llc Nucleotides for the treatment of liver cancer

Also Published As

Publication number Publication date
GB201609602D0 (en) 2016-07-13
ZA201807810B (en) 2021-04-28
WO2017207989A1 (en) 2017-12-07
CL2018003444A1 (es) 2019-05-10
PH12018502497A1 (en) 2019-04-08
US20190375778A1 (en) 2019-12-12
KR20190015355A (ko) 2019-02-13
MX2018014849A (es) 2019-03-14
SG11201810146SA (en) 2018-12-28
JP2019520345A (ja) 2019-07-18
IL263120A (en) 2018-12-31
CN109563122A (zh) 2019-04-02
EP3464308A1 (en) 2019-04-10
EP3464308B1 (en) 2020-08-19
BR112018074972A2 (pt) 2019-03-12
CA3025435A1 (en) 2017-12-07
AU2017273120A1 (en) 2018-12-06

Similar Documents

Publication Publication Date Title
EA201892802A1 (ru) Производные аденозина для применения при лечении рака
BR112018003269A2 (pt) conjugados de fármaco-anticorpo anti-dll3 e métodos de utilização
CY1124798T1 (el) Υποκατεστημενα παραγωγα καρβονουκλεοζιδιων χρησιμα ως παραγοντες κατα των καρκινων
EA201790413A1 (ru) Антитела против tigit
EA201890204A1 (ru) Антибактериальные соединения
EA201990043A1 (ru) Антибактериальные соединения
EA201791563A1 (ru) Замещенные нуклеозидные производные, полезные в качестве агентов против рака
EA201790273A1 (ru) Флагеллиновые композиции и их применение
EA201791867A1 (ru) Бициклические гетероциклы как ингибиторы fgfr4
EA201890754A1 (ru) Соединения и способы их применения
CL2015001985A1 (es) Compuestos de tiazolcarboxamidas y piridinacarboxamida, inhibidores de quinasa pim.
TR201819138T4 (tr) FGFR Kinaz Modülatörleri Olarak Faydalı Kinoksalin Türevleri
EA201590997A1 (ru) Соединения и способы их применения
EA201591524A1 (ru) Производные 2-аминопиримидина для лечения вирусных инфекций
EA201591887A1 (ru) Макроциклические деазаоксипурины для лечения вирусных инфекций
EA201692526A1 (ru) Замещенные [1,2,4]триазольные соединения
EA201990296A1 (ru) Антитела против siglec-7 для лечения рака
EA201691845A1 (ru) Фармацевтические композиции терапевтически активных соединений
EA201692100A1 (ru) Новые антитела против rnf43 и способы их применения
EA201691844A1 (ru) Фармацевтические композиции терапевтически активных соединений
BR112018010279A2 (pt) novos anticorpos anti-emr2 e métodos de uso
MX2019013808A (es) Compuestos desestabilizadores de microtubulina para usarse en el tratamiento del cancer.
EA201692358A1 (ru) Производные изоиндолина для применения в лечении вирусной инфекции
CL2016001937A1 (es) Compuestos de benzopirano funcionalizados y uso de los mismos
EA201790156A1 (ru) Азетидинилоксифенилпирролидиновые соединения